C-reactive Protein for Stroke Detection in the Emergency Department in Patients With Dizziness Without Neurological

Seok-In Hong1, June-Sung Kim1, Hong Jun Bae1

  • 1Department of Emergency Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Insights

C-reactive protein (CRP) does not reliably predict acute stroke in patients experiencing dizziness without neurological deficits. This study found no significant association between CRP levels and stroke diagnosis in this patient group.

Area of Science:

  • Neurology
  • Emergency Medicine
  • Biomarkers

Background:

  • Diagnosing stroke in patients with dizziness and no neurological deficits presents a clinical challenge.
  • C-reactive protein (CRP) is an inflammatory marker, and its utility in acute stroke detection in this specific population requires investigation.

Purpose of the Study:

  • To assess the predictive value of serum C-reactive protein (CRP) levels for identifying acute stroke in emergency department patients presenting with dizziness but no neurological deficits.

Main Methods:

  • Retrospective analysis of 1,188 adult patients admitted between August 2019 and February 2020.
  • Serum CRP levels measured within 2 hours of arrival, alongside brain MRI.
  • Univariable and multivariable logistic regression models were used to analyze the relationship between CRP and acute stroke.

Main Results:

  • Acute stroke was identified in 4.4% of patients (n=53).
  • No significant difference in CRP levels was observed between acute stroke and non-stroke groups (P=0.074).
  • CRP did not show statistically significant predictive value for acute stroke (AUC=0.567, P=0.101); age, prior stroke history, WBC, and hemoglobin were associated with stroke.

Conclusions:

  • Serum CRP levels lack significant discriminative value for diagnosing acute stroke in patients with dizziness and no clear neurological deficits.
  • Clinical judgment and other diagnostic tools remain crucial for stroke detection in this cohort.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
58
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
283
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
158
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
464